日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Integration of Single-cell and Bulk Transcriptome Analyses Unravels a Macrophage-based Gene Signature for Prognostication and Treatment in Triple-negative Breast Cancer

单细胞和批量转录组分析的整合揭示了基于巨噬细胞的基因特征,可用于三阴性乳腺癌的预后和治疗

Huang, Yuan; Yu, Yuan; Zhu, Yufei; Lu, Qianhui; Zhang, Ziwen; Wang, Xiaojia; Wang, Xiaowei; Zheng, Yabing

Therapeutic targeting of interleukin-17C signaling in carcinogenesis of endometriosis

治疗靶向白细胞介素-17C信号通路在子宫内膜异位症癌变中的作用

Bo Yao,Ruxin Zheng,Yabing Yang,Zhan Zhao,Gendie E Lash,Bihui Guo,Jinghua Pan,Hanlin Shuai,Hong Zhou,Minghua Wang,Ping Li

Inetetamab for injection in combination with vinorelbine weekly or every three weeks in HER2-positive metastatic breast cancer: A multicenter, randomized, phase II clinical trial

伊奈妥单抗注射液联合长春瑞滨每周或每三周一次治疗HER2阳性转移性乳腺癌:一项多中心、随机、II期临床试验

Shao, Xiying; Xie, Ning; Chen, Zhanhong; Wang, Xinshuai; Cao, Wenming; Zheng, Yabing; Yang, Hua; Huang, Jian; Chen, Shaoping; Gan, Lu; Yang, Xiuli; Chen, Yuru; Ouyang, Quchang; Wang, Xiaojia

Pyrotinib plus docetaxel as first-line treatment for HER2-positive metastatic breast cancer: the PANDORA phase II trial

吡咯替尼联合多西他赛作为HER2阳性转移性乳腺癌一线治疗:PANDORA II期试验

Zheng, Yabing; Cao, Wen-Ming; Shao, Xiying; Shi, Yanxia; Cai, Li; Chen, Wenyan; Liu, Jian; Shen, Peng; Chen, Yiding; Wang, Xian; Li, Huiping; Li, Man; Chen, Zhanhong; Wang, Xiaojia

Use of period analysis to timely assess 5-year relative survival for breast cancer patients from Taizhou, Eastern China

利用时期分析法及时评估中国东部台州市乳腺癌患者的5年相对生存率

Li, Runhua; Zheng, Yabing; Huang, Jiajia; Lei, Huijun; Xu, Mingzhi; Wang, Liangyou; Zhang, Luyao; Cheng, Yongran; Jiang, Xiyi; Tang, Huijuan; Shi, Zheng; Chen, Gang; Zhou, Huijuan; Dai, Zhijun; Lu, Dalin; Chen, Tianhui

Real-World First-Line Treatment Patterns and Outcomes in Hormone Receptor-Positive Advanced Breast Cancer Patients: A Multicenter, Retrospective Study in China

中国一项多中心回顾性研究:激素受体阳性晚期乳腺癌患者一线治疗模式及疗效的真实世界研究。

Chen, Zhanhong; Ouyang, Quchang; Wang, Yongsheng; Wang, Junsheng; Wang, Haixue; Wu, Xiaohong; Zhang, Peili; Huang, Jian; Zheng, Yabing; Cao, Wenming; Shao, Xiying; Xie, Ning; Tian, Can; Liang, Hao; Wang, Cailing; Zhang, Ying; Ren, Dianquan; Wang, Xiaojia

Real-world effectiveness of eribulin in heavily pretreated patients with metastatic breast cancer in China: a multicenter retrospective study

在中国,艾立布林在既往接受过大量治疗的转移性乳腺癌患者中的真实世界疗效:一项多中心回顾性研究

Zhao, Yannan; Xie, Ning; Li, Wei; Chen, Wenyan; Lv, Zheng; Zheng, Yabing; Sun, Tao; Liu, Jieqiong; Zhang, Jian; Hu, Shihui; Wang, Yajun; Gong, Chengcheng; Li, Yi; Xie, Yizhao; Ge, Rui; Xu, Fei; Wang, Biyun

Differences in the clinicopathological characteristics of pure and mixed invasive micropapillary breast carcinomas from eastern China

中国东部纯型和混合型浸润性微乳头状乳腺癌临床病理特征的差异

Wang, Rong; Li, Nani; Wang, Xiao-Jia; Chen, Tianhui; Zhang, Hong; Cheng, Yongran; Sun, Wenyong; Chen, Zhanhong; Zheng, Yabing; Lizaso, Analyn; Chen, Songan; Cao, Wen-Ming

Ki67 and progesterone receptor status predicts sensitivity to palbociclib: a real-world study

Ki67 和孕激素受体状态可预测对帕博西尼的敏感性:一项真实世界研究

Shao, Xiying; Zheng, Yabing; Cao, Wenming; Shen, Xiabo; Li, Guangliang; Chen, Junqing; Huang, Yuan; Huang, Ping; Shi, Lei; Ye, Weiwu; Zou, Weibin; Lou, Caijin; Lei, Lei; Huang, Jian; Chen, Zhanhong; Wang, Xiaojia

Exploring the concepts and practices of advanced breast cancer treatment: a narrative review

探索晚期乳腺癌治疗的概念和实践:一篇叙述性综述

Wang, Xiaojia; Shao, Xiying; Huang, Jian; Lei, Lei; Huang, Yuan; Zheng, Yabing; Cao, Wenming; Chen, Zhanhong